(2S,3R)-3-(3-Carboxy-4-methylphenyl)pyrrolidine-2-carboxylic Acid Hydrochloride

ID: ALA4102488

Chembl Id: CHEMBL4102488

PubChem CID: 90344476

Max Phase: Preclinical

Molecular Formula: C13H16ClNO4

Molecular Weight: 249.27

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc([C@H]2CCN[C@@H]2C(=O)O)cc1C(=O)O.Cl

Standard InChI:  InChI=1S/C13H15NO4.ClH/c1-7-2-3-8(6-10(7)12(15)16)9-4-5-14-11(9)13(17)18;/h2-3,6,9,11,14H,4-5H2,1H3,(H,15,16)(H,17,18);1H/t9-,11+;/m1./s1

Standard InChI Key:  IEMBOYVGGOVPFL-XQKZEKTMSA-N

Associated Targets(non-human)

Grik1 Glutamate receptor ionotropic kainate 1 (319 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grik2 Glutamate receptor ionotropic kainate 2 (298 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grik3 Glutamate receptor ionotropic kainate 3 (207 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 249.27Molecular Weight (Monoisotopic): 249.1001AlogP: 1.22#Rotatable Bonds: 3
Polar Surface Area: 86.63Molecular Species: ZWITTERIONHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 1.39CX Basic pKa: 11.38CX LogP: -0.97CX LogD: -4.17
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.75Np Likeness Score: 0.36

References

1. Gynther M, Proietti Silvestri I, Hansen JC, Hansen KB, Malm T, Ishchenko Y, Larsen Y, Han L, Kayser S, Auriola S, Petsalo A, Nielsen B, Pickering DS, Bunch L..  (2017)  Augmentation of Anticancer Drug Efficacy in Murine Hepatocellular Carcinoma Cells by a Peripherally Acting Competitive N-Methyl-d-aspartate (NMDA) Receptor Antagonist.,  60  (23): [PMID:29205034] [10.1021/acs.jmedchem.7b01624]

Source